Stage A & C Sample Data Collection Form
|
|
|
- Russell O’Brien’
- 9 years ago
- Views:
Transcription
1 Stage A & C Sample Data Collection Form Instructions: Review a minimum of 20 patient charts (or another number determined to be appropriate) from patients most recently admitted, and complete this Data Collection Form, one form per patient chart. This form and the questions included can be customized to meet your needs. The questions relating to specific performance measures are identified (*) other questions are included to provide additional information should you be interested in analyzing it. 1. Patient ID (assign a unique identifier to help you track, should you need to review the patient chart at a later time) 2. Gender Male Female 3. Age Under Ethnicity African American Asian Caucasian Latino/Hispanic Other
2 5. Date of first visit (mm/yyyy) 6. Date of MS diagnosis (mm/yyyy) * 7. Has the patient been assessed for symptoms of DEPRESSION? 8. Was the patient assessed for depression at first visit? NA (not available) 9. How were the patient s depression symptoms assessed? (check all that apply) Two-question screening test Beck Depression Inventory (BDI) Patient Health Questionnaire (PHQ-9) Other: * 10. Was a diagnosis of depression made? (If you answered for this patient, please skip to question #16) * 11. Is there a documented care plan for managing the patient s depression? 12. If yes, what is included in the care plan? (check all that apply) Psychiatric Referral Pharmacotherapy (single medication) Pharmacotherapy (more than one medication) 13. Is there documented periodic assessment of effectiveness of depression management?
3 14. Were assessments made at every visit? 15. Was there a change in medication or dose based on the reassessment? * 16. Has the patient been assessed for symptoms of FATIGUE? 17. Was the patient assessed for fatigue at first visit? NA (not available) 18. How were the patient s fatigue symptoms assessed? (check all that apply) Patient detailed history Krupp s Fatigue Severity Scale (FSS) Modified Fatigue Impact Scale (MFIS) Other: * 19. Were fatigue symptoms recorded for this patient? (If you answered for this patient, please skip to question #27) * 20. Is there a documented care plan for managing the patient s fatigue? 21. If yes, what is included in the care plan? (check all that apply) Behavioral Modification (eg, pacing or relaxation) Pharmacotherapy (single medication) Pharmacotherapy (more than one medication) Other
4 22. Is there documented periodic assessment of effectiveness of fatigue management? 23. Were assessments made at every visit? 24. Has the plan been modified based on reassessment of the patient s fatigue? 25. Was there a change in non-pharmacologic therapy based on the reassessment? 26. Was there a change in medication or dose based on the reassessment? * 27. Has the patient been assessed for MOBILITY IMPAIRMENTS/FALLS? 28. If yes, was the patient s mobility assessed at first visit? NA (not available) 29. How was the patient s mobility assessed? (check all that apply) Neurological Exam Expanded Disability Status Scale (EDSS) 12-item MS walking scale (MSWS-12) Timed 25-foot walk test Other:
5 30. Which level of ambulation was recorded for the patient? Requires no assistance Requires minimal assistance (eg, handrail) Requires cane or walker Requires wheelchair or scooter ambulation level recorded * 31. Were mobility impairments/falls recorded for this patient? (If you answered for this patient, please skip to question #39) * 32. Is there a documented care plan for managing the patient s mobility impairments? 33. If yes, what is included in the care plan? (check all that apply) Physical therapy/rehabilitation Pharmacotherapy (single medication) Pharmacotherapy (more than one medication) 34. Is there documented periodic assessment of effectiveness of mobility management? 35. Were assessments made at every visit? 36. Has the plan been modified based on reassessment of the patient s mobility? 37. Was there a change in non-pharmacologic therapy based on the reassessment?
6 38. Was there a change in medication or dose based on the reassessment? * 39. Has the patient been assessed for symptoms of SPASTICITY? 40. If yes, was the patient assessed for spasticity at first visit? NA (not available) 41. How were the patient s spasticity symptoms assessed? (check all that apply) Ashworth or Modified Ashworth score Neurological Exam Other: * 42. Were spasticit y symptoms recorded for this patient? (If you answered for this patient, stop here) * 43. Is there a documented care plan for managing the patient s spasticity symptoms? 44. If yes, what is included in the care plan? (check all that apply) Physical therapy/rehabilitation Pharmacotherapy (single medication) Pharmacotherapy (more than one medication) 45. Is there documented periodic assessment of effectiveness of spasticity management? 46. Were assessments made at every visit?
7 47. Has the plan been modified based on reassessment of the patient s spasticity? 48. Was there a change in non-pharmacologic therapy based on the reassessment? 49. Was there a change in medication or dose based on the reassessment?
8 Measure # I II Constructing an Adaptive Care Model for the Management of Disease Related Symptoms Throughout the Course of Multiple Sclerosis Performance Measures and Calculation Instructions Symptom Performance Measure Numerator Numerator Calculation Depression documented assessment documented care plan assessment for depression care plan for managing depression of "" responses to Question 7 of "" responses to Question 11 Denominator All residents All residents with documented diagnosis of depression Denominator Calculation number of patient charts reviewed number of "" responses to Question 10 III IV V VI Fatigue Mobility Impairment/ Falls documented assessment documented care plan documented assessment documented care plan assessment for fatigue care plan for managing fatigue assessment for mobility impairments/falls care plan for managing mobility impairments of "" responses to Question 16 of "" responses to Question 20 of "" responses to Question 27 of "" responses to Question 32 All residents All residents with documented fatigue symptoms All residents All residents with documented mobility impairment/falls number of patient charts reviewed number of "" responses to Question 19 number of patient charts reviewed number of "" responses to Question 31 VII VIII Spasticity documented assessment documented care plan assessment for symptoms of spasticity care plan for managing spasticity of "" responses to Question 39 of "" responses to Question 43 All residents All residents with documented spasticity symptoms number of patient charts reviewed number of "" responses to Question 42 Source: Cheng et al. Quality indicators for MS. Multiple Sclerosis. 2010;16(8): The Academy for Continued Healthcare Learning.
Clinical Study Synopsis
Clinical Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website. It is provided for patients and healthcare professionals to increase the transparency of
Mellen Center for Multiple Sclerosis
Mellen Center Cleveland Clinic Marie Namey, RN, MSN, MSCN Mellen Center Cleveland Clinic Cleveland, OH Home of. Mellen Center for Multiple Sclerosis Mellen Center Mission The Mellen Center remains committed
WAKE-Up Pilot Study, Mental Training for patients with relapse-remitting multiple sclerosis and fatigue
PLEASE NOTE: This trial has been registered retrospectively. Trial Description Title WAKE-Up Pilot Study, Mental Training for patients with relapse-remitting multiple sclerosis and fatigue Trial Acronym
DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource
E-Resource March, 2015 DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource Depression affects approximately 20% of the general population
CADC-CAS STUDY GUIDE. Studying for the Exam. Exam Content Outline
CADC-CAS STUDY GUIDE Studying for the Exam The exam covers the following topic areas. Candidates are encouraged to review these areas and the items listed below in preparation for the exam. All questions
Equipment Distribution Program Application 375 Kings Highway North, Cherry Hill, NJ 08034 (800) 532-7667 Web: www.mymsaa.org
Equipment Distribution Program Application 375 Kings Highway North, Cherry Hill, NJ 08034 (800) 532-7667 Web: www.mymsaa.org Application for Safety, Mobility, and Daily Living Products Individuals with
PACKET OVERVIEW TABLE OF CONTENTS
PACKET OVERVIEW The OYA conducts a mental health/substance abuse survey every two years on all offenders in OYA custody. The resulting data is analyzed to detect gaps in youth services and is used to advocate
PCORI Workshop on Treatment for Multiple Sclerosis. Breakout Group Topics and Questions Draft 3-27-15
PCORI Workshop on Treatment for Multiple Sclerosis Breakout Group Topics and Questions Draft 3-27-15 Group 1 - Comparison across DMTs, including differential effects in subgroups Consolidated straw man
College Survey for Students with Brain Injury
Name Date Interviewer I. Demographics 1. Please fill in the following: (MM/DD/YYYY) (1) Date of birth / / (2) Date of brain injury (please estimate if you are not certain) / / 2. Sex (circle) Female Male
Multiple Sclerosis: New Perspectives on the Patient Journey
Multiple Sclerosis: New Perspectives on the Patient Journey Prepared by Milliman, Inc., NY Bruce Pyenson, FSA, MAAA Principal and Consulting Actuary Melissa Fredericks, FSA, MAAA Principal and Consulting
Fatigue in MS: 2005 update B. Colombo University of Milan - HSR
Fatigue in MS: 2005 update B. Colombo University of Milan - HSR Fatigue in MS One of the more disabling symptoms Affects about 75/90 % of the patients May be the onset symptom Transient or chronic May
WalkAide. Long term cost effectiveness of FES. J of Rehab Med 2013; 45(2):154 60 Humphreys et al
WalkAide Long term cost effectiveness of FES J of Rehab Med 2013; 45(2):154 60 Humphreys et al 126 people (62 stroke, 39 MS, 7 SCI, 3 CP, 15 other) Mean time of FES use 3.6 years 33 using FES after 11.1
Running Head: INTERNET USE IN A COLLEGE SAMPLE. TITLE: Internet Use and Associated Risks in a College Sample
Running Head: INTERNET USE IN A COLLEGE SAMPLE TITLE: Internet Use and Associated Risks in a College Sample AUTHORS: Katherine Derbyshire, B.S. Jon Grant, J.D., M.D., M.P.H. Katherine Lust, Ph.D., M.P.H.
Version History. Previous Versions. Drugs for MS.Drug facts box fampridine Version 1.0 Author
Version History Policy Title Drugs for MS.Drug facts box fampridine Version 1.0 Author West Midlands Commissioning Support Unit Publication Date Jan 2013 Review Date Supersedes/New (Further fields as required
A blood sample will be collected annually for up to 2 years for JCV antibody testing.
Mellen Center Currently Enrolling Non-Treatment Trials STRATIFY-2 JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri Primary Investigator:
Drugs for MS.Drug fact box cannabis extract (Sativex) Version 1.0 Author
Version History Policy Title Drugs for MS.Drug fact box cannabis extract (Sativex) Version 1.0 Author West Midlands Commissioning Support Unit Publication Date Jan 2013 Review Date Supersedes/New (Further
What is Multiple Sclerosis? Gener al information
What is Multiple Sclerosis? Gener al information Kim, diagnosed in 1986 What is MS? Multiple sclerosis (or MS) is a chronic, often disabling disease that attacks the central nervous system (brain and spinal
PHYSICAL CAPACITIES EVALUATION FORM/RESIDUAL FUNCTIONAL CAPACITY ASSESSMENT FORM
PHYSICAL CAPACITIES EVALUATION FORM/RESIDUAL FUNCTIONAL CAPACITY ASSESSMENT FORM ACTUAL SAMPLE (Note: This is an example of the specificity with which this form should be completed to be useful for the
Depression: Facility Assessment Checklists
Depression: Facility Assessment Checklists A facility system assessment is a starting point for a quality improvement project. The checklists included in this booklet will be most useful if you take a
MS an Mental Health. Alison Carolan MS Mental Health Nurse Kings College Hospital. IMPARTS December 2013
MS an Mental Health Alison Carolan MS Mental Health Nurse Kings College Hospital IMPARTS December 2013 MS and Mental Health MS is an autoimmune disease MS carries high risk of common mental disorders and
Application for MetroAccess Door-to-Door Paratransit Service For People with Disabilities
Application for MetroAccess Door-to-Door Paratransit Service For People with Disabilities DO NOT MAIL OR FAX APPLICATION Transit Accessibility Center 600 5 th Street, NW Washington, DC 20001 (Between Chinatown/Gallery
Austen Riggs Center Patient Demographics
Number of Patients Austen Riggs Center Patient Demographics Patient Gender Patient Age at Admission 80 75 70 66 Male 37% 60 50 56 58 48 41 40 Female 63% 30 20 10 18 to 20 21 to 24 25 to 30 31 to 40 41
The Relationship Between Anhedonia & Low Mood
Rebecca M. Floyd, Ph.D., Kimberly Lewis, Ph.D., Eliot Lopez, M.S., Thomas Toomey, B.A., Kena Arnold, B.A., and Lara Stepleman, Ph.D. The lifetime prevalence of depression in patients with MS is approximately
MSTAC Initial Application
MSTAC Initial Application Please send applications to: Facsimile 04 916 7571 Further Contact Details: Address The Co-ordinator MSTAC PHARMAC P O Box 10-254 WELLINGTON Phone 04 460 4990 Email [email protected]
TECHNICAL/CLINICAL TOOLS BEST PRACTICE 7: Depression Screening and Management
TECHNICAL/CLINICAL TOOLS BEST PRACTICE 7: Depression Screening and Management WHY IS THIS IMPORTANT? Depression causes fluctuations in mood, low self esteem and loss of interest or pleasure in normally
A New MS Consortium for A New MS Clinical Outcome Measure
A New MS Consortium for A New MS Clinical Outcome Measure Nicholas G. LaRocca, Ph.D. Richard Rudick, M.D. Lynn Hudson, Ph.D. Co-Directors, MSOAC American Academy of Neurology March 20 th, 2013 The problem
GLOBAL SURVEY FACT SHEET
Multiple sclerosis (MS) is a chronic, often disabling, disease that attacks the central nervous system, which is made up of the brain, spinal cord, and optic nerves. Symptoms may be mild or severe, ranging
Sleep Deprivation and Post-Treatment (CBD)
Population Authors & year Design Intervention (I) and Comparison (C) Mean age (SD) 1 Gender (%) Delivered to Dosage (total number of sessions) Primary Outcome domain (Measure(s)) Secondary Outcome domain
Multiple Sclerosis Society of Canada. CADA Presentation May 4, 2011
Multiple Sclerosis Society of Canada CADA Presentation May 4, 2011 1 MS Society s Mission To be a leader in finding a cure for multiple sclerosis and enabling people affected by MS to enhance their quality
MOLINA HEALTHCARE OF CALIFORNIA
MOLINA HEALTHCARE OF CALIFORNIA MAJOR DEPRESSION IN ADULTS IN PRIMARY CARE HEALTH CARE GUIDELINE (ICSI) Health Care Guideline Twelfth Edition May 2009. The guideline was reviewed and adopted by the Molina
Major Depressive Disorder (MDD) Guideline Diagnostic Nomenclature for Clinical Depressive Conditions
Major Depressive Disorder Major Depressive Disorder (MDD) Guideline Diagnostic omenclature for Clinical Depressive Conditions Conditions Diagnostic Criteria Duration Major Depression 5 of the following
Disease Modifying Therapies (DMTs) in Multiple Sclerosis
Disease Modifying Therapies (DMTs) in Multiple Sclerosis Gary Stobbe, MD Medical Director, MS Project ECHO Clinical Assistant Professor, UW Neurology Conflict of Interest Dr. Stobbe has no conflicts of
Ryokan College Student Profile Program Completion Rates from 1991 to 2011 Program & Graduation Rate Student 85%
Ryokan College Student Profile Program Completion Rates from 1991 to 2011 Program & Graduation Rate Student 85% 95% Over All Graduation Rate--all programs since 1991 Program: BA - Bachelor of Arts - Human
Depressive Symptoms Quality Measures Skilled Nursing Facility Setting
Depressive Symptoms Quality Measures Skilled Nursing Facility Setting Prepared for: CMS Quality Measures Work Group Forum 21 June 2012 Moderate/Severe Depressive Symptoms Care Plan Measure (long-stay;
Screening Tools and Interventions for Common Behavioral Health Disorders TXPEC-0772-13
Screening Tools and Interventions for Common Behavioral Health Disorders TXPEC-0772-13 Screening Tools and Interventions for Common Behavioral Health Disorders Depression Depression is a potentially life-threatening
Understanding COPD Questionnaire
Further information about the UCOPD questionnaire is available from http://www.science.ulster.ac.uk/ucopd/ or by contacting Dr Brenda O Neill ([email protected]) Understanding COPD Questionnaire Patient
PAIN MANAGEMENT. Patient s name: IF YOUR INSURANCE REQUIRES A PRE AUTHORIZATION / REFERRAL FORM, PLEASE OBTAIN PRIOR TO YOUR VISIT.
PAIN MANAGEMENT Please fill out the following questionnaire and bring it with you to your appointment. In addition, bring your medication list and Reports of any X- rays, MRI or Cat scans. Patient s name:
Prior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management
Prior Authorization, Pharmacy and Health Case Management Information The purpose of this information sheet is to provide you with details on how Great-West Life will be assessing and managing your claim
Rehabilitation and the role of carers
Rehabilitation and the role of carers Dr Jacinta Morgan Consultant in Rehabilitation Medicine National Clinical Lead, Rehabilitation Medicine Programme (HSE CSPD) EMSP Spring Conference Gibson Hotel Dublin,
BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 [email protected] www.bpsweb.
BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 [email protected] www.bpsweb.org Content Outline for the PSYCHIATRIC PHARMACY SPECIALTY
Total Males Females 34.4 36.7 (0.4) 12.7 17.5 (1.6) Didn't believe entitled or eligible 13.0 (0.3) Did not know how to apply for benefits 3.4 (0.
2001 National Survey of Veterans (NSV) - March, 2003 - Page 413 Table 7-10. Percent Distribution of Veterans by Reasons Veterans Don't Have VA Life Insurance and Gender Males Females Not Applicable 3,400,423
Lisa R. Fortuna, MD, MPH Michelle V. Porche, Ed. D Sripallavi Morampudi, MBBS Stanley Rosenberg, PhD Douglas Ziedonis, MD, MPH
CBT for Youth with Co-Occurring Post Traumatic Stress Disorder and Substance Disorders Lisa R. Fortuna, MD, MPH Michelle V. Porche, Ed. D Sripallavi Morampudi, MBBS Stanley Rosenberg, PhD Douglas Ziedonis,
Relapsing-remitting multiple sclerosis Ambulatory with or without aid
AVONEX/BETASERON/COPAXONE/EXTAVIA/GILENYA/REBIF/TYSABRI Applicant must be covered on an Alberta Government sponsored drug program. Page 1 of 5 PATIENT INFMATION Surname First Name Middle Initial Sex Date
WHODAS 2.0 World Health Organization Disability Assessment Schedule 2.0 36-item version, self-administered
The APA is offering a number of emerging measures for further research and clinical evaluation. These patient assessment measures were developed to be administered at the initial patient interview and
Multiple Sclerosis: What You Need To Know. For Professionals
Multiple Sclerosis: What You Need To Know For Professionals What will I learn today? The Basics: What is MS? Living with MS: A Family Affair We Can Help: The National MS Society What MS Is: MS is thought
Major Depressive Disorders Questions submitted for consideration by workshop participants
Major Depressive Disorders Questions submitted for consideration by workshop participants Prioritizing Comparative Effectiveness Research Questions: PCORI Stakeholder Workshops June 9, 2015 Patient-Centered
Case: Cerebral Palsy
Case: Cerebral Palsy A.W. is a 48 y.o. AA female with diplegic Cerebral Palsy(CP) Dysphagia, coughing, with solid foods X 3 mo. Vague generalized abdominal pain intermittently, 3 lb wt loss Seizure disorder
Worksite Depression Screening and Treatment: An Innovative, Integrated Program
Photos placed in horizontal position with even amount of white space between photos and header Photos placed in horizontal position with even amount of white space between photos and header Worksite Depression
Substance Abuse Services (Outpatient)
RYAN WHITE PART B PEER REVIEW 2009-2010 Virginia Department of Health Division of Disease Prevention HIV Care Services Chart Review Substance Abuse Services (Outpatient) ID# 1. Is there referral in the
BACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes
BACKGROUND More than 25% of people with diabetes take insulin ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes Insulin identified as the most effective
Psychological Self Care in Multiple Sclerosis: A Stepped Care Model
Psychological Self Care in Multiple Sclerosis: A Stepped Care Model Dr Dawn Reeve Consultant Clinical Neuropsychologist Mrs Dawn Anderson Self Care Development Manager Background to service evaluation
Review Date: March 2012. Issue Status: Approved Issue No: 2 Issue Date: March 2010
Title: Multiple Sclerosis guidelines for the use of beta-interferon, glatiramer acetate, natalizumab, mitoxantrone and other disease Authors Name: Dr P Talbot Contact Name: Dr Paul Talbot Contact Phone
DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE
1 DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE ASSESSMENT/PROBLEM RECOGNITION 1. Did the staff and physician seek and document risk factors for depression and any history of depression? 2. Did staff
Dr. Anna M. Acee, EdD, ANP-BC, PMHNP-BC Long Island University, Heilbrunn School of Nursing
Dr. Anna M. Acee, EdD, ANP-BC, PMHNP-BC Long Island University, Heilbrunn School of Nursing Overview Depression is significantly higher among elderly adults receiving home healthcare, particularly among
Schneps, Leila; Colmez, Coralie. Math on Trial : How Numbers Get Used and Abused in the Courtroom. New York, NY, USA: Basic Books, 2013. p i.
New York, NY, USA: Basic Books, 2013. p i. http://site.ebrary.com/lib/mcgill/doc?id=10665296&ppg=2 New York, NY, USA: Basic Books, 2013. p ii. http://site.ebrary.com/lib/mcgill/doc?id=10665296&ppg=3 New
CROSSROADS ENROLLMENT APPLICATION (Please carefully read and print all answers. All blank spaces must be filled.)
P a g e 1 CROSSROADS ENROLLMENT APPLICATION (Please carefully read and print all answers. All blank spaces must be filled.) Personal Information Today s Date: Name: First: M.I.: Last: Preferred Name: Maiden
PSYCHOLOGICAL AND NEUROPSYCHOLOGICAL TESTING
Status Active Medical and Behavioral Health Policy Section: Behavioral Health Policy Number: X-45 Effective Date: 01/22/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members
University of Georgia Honors Program
Name: University of Georgia Honors Program IMPORTANT REQUIRED INFORMATION Have you already applied for admission to the University of Georgia? Yes No Have you been admitted to the University of Georgia
REVISED E-Health Patient Screening Survey
REVISED E-Health Patient Screening Survey The Patient screening survey will be administered online after the patient has electronically signed the patient consent form. 1 E-Health Patient Screening Survey
Measurement Tool for Clinical Practice Guideline Implementation: Measures for Depression
ment Tool for Clinical Practice Guideline : Establish process and clinical outcomes measures before implementing the Depression in the Long Term Care Setting Clinical Practice Guideline (CPG). As much
SCAT Application. (1) SCAT Eligibility Questionnaire Form and (2) Professional Verification Form
The has two different forms and both forms must be completed and received by GTA either prior to the in-person interview, or brought to the interview: (1) SCAT Eligibility Questionnaire Form and (2) Professional
A Quick Guide to Constructing an SPSS Code Book Prepared by Amina Jabbar, Centre for Research on Inner City Health
A Quick Guide to Constructing an SPSS Code Book Prepared by Amina Jabbar, Centre for Research on Inner City Health 1. To begin, double click on SPSS icon. The icon will probably look something like this
Staying Mobile & Active Post Stroke. Kevin Lockette PT Ohana Pacific Rehab Services, LLC Honoulu- Kailua www.ohanapacificrehab.
Staying Mobile & Active Post Stroke Kevin Lockette PT Ohana Pacific Rehab Services, LLC Honoulu- Kailua www.ohanapacificrehab.com 808 262 1118 Aging Process Changes in body composition Loss of muscle tissue/increase
Adult Foster Home Screening and Assessment and General Information
Office of Licensing and Regulatory Oversight Resident information Resident s name: Resident s current address: Resident s current living situation: Resident s current primary caregiver: Adult Foster Home
Disclosures. Andrew Moore, LPC has no financial i interests or relationships to disclose. HRSA Education Committee staff have no financial interest
Behavioral Health in Oklahoma Andrew Moore, LPC Sponsored Programs Coordinator Ryan White Part B & D and CRCS University of Oklahoma Health Sciences Center Comprehensive HIV/AIDS Resources & Treatment
CCC Hooper Detoxification Stabilization Center. Accessing Services
CCC Hooper Detoxification Stabilization Center Accessing Services Overview Access / Admissions Subacute Program Discharge / Referral Access / Admissions : Current Process 4 groups: Each triaged independently
Robot suit HAL. The use of exoskeletons in rehabilitation and as assistive technology to enable equal participation
Robot suit HAL The use of exoskeletons in rehabilitation and as assistive technology to enable equal participation Feasibility Study Man Machine Interface Robot Suit MMIRS (Feb 2013 June 2015) Dr. Grit
Application for Transportation Service
Application for Transportation Service (Please complete one form per rider) Person completing this form is: Rider Family Member Other Type of Membership: Individual Family (2 or more in Household) Family
Assessment of depression in adults in primary care
Assessment of depression in adults in primary care Adapted from: Identification of Common Mental Disorders and Management of Depression in Primary care. New Zealand Guidelines Group 1 The questions and
Annual Outcome Comparison Report-Source One/Village Jan 1, thru Dec 31, 2013
1 SOURCE ONE REHAB Annual Outcome Comparison Report-Source One/Village Jan 1, thru Dec 31, 2013 This report was presented to the stakeholders and Board of Directors. Index to this report: Overall program
International Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014
International Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014 http://ijecm.co.uk/ ISSN 2348 0386 HEALTHCARE MANAGEMENT AND PSYCHOLOGICAL WELL-BEING IN PATIENTS WITH
Neurodegenerative diseases Includes multiple sclerosis, Parkinson s disease, postpolio syndrome, rheumatoid arthritis, lupus
TIRR Memorial Hermann is a nationally recognized rehabilitation hospital that returns lives interrupted by neurological illness, trauma or other debilitating conditions back to independence. Some of the
Estimated Population Responding on Item 25,196,036 2,288,572 3,030,297 5,415,134 4,945,979 5,256,419 4,116,133 Medicare 39.3 (0.2)
Table 3-15. Percent Distribution of Veterans by Type of Health Insurance and Age 35 Years 35-44 Years 2001 National Survey of Veterans (NSV) - March, 2003 - Page 140 45-54 Years 55-64 Years 65-74 Years
Foot and Ankle Outcomes Questionnaire
Foot and Ankle Outcomes Questionnaire Developed by: American Academy of Orthopaedic Surgeons American Association of Hip and Knee Surgeons American Orthopaedic Society for Sports Medicine Hip Society Knee
Prior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management
Prior Authorization, Pharmacy and Health Case Management Information The purpose of this information sheet is to provide you with details on how Great-West Life will be assessing and managing your claim
